Which companies overlap with Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.'s portfolio?

No competitive overlap detected.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/uni-pharma-kleon-tsetis-pharmaceutical-laboratories-s-a.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. pipeline: 2 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Fe-ASP	Fe-ASP	marketed	Asparaginase conjugate	Asparagine synthetase (indirect target via asparagine depletion)	Oncology
APOTEL max	APOTEL max	marketed	Analgesic combination		Pain Management

Therapeutic area mix

Oncology · 1
Pain Management · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

No competitive overlap data.

Subscribe to ongoing alerts

Every new pipeline event for Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.:

Cite this brief

Drug Landscape (2026). Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/uni-pharma-kleon-tsetis-pharmaceutical-laboratories-s-a. Accessed 2026-05-17.